DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)
19.35
+0.60 (3.20%)
Apr 29, 2026, 3:00 PM CST
8.95% (1Y)
| Market Cap | 21.35B |
| Revenue (ttm) | 27.52B |
| Net Income (ttm) | 1.29B |
| Shares Out | 1.14B |
| EPS (ttm) | 1.13 |
| PE Ratio | 16.62 |
| Forward PE | 15.62 |
| Dividend | 0.68 (3.63%) |
| Ex-Dividend Date | Nov 6, 2025 |
| Volume | 9,934,971 |
| Average Volume | 5,815,058 |
| Open | 18.89 |
| Previous Close | 18.75 |
| Day's Range | 18.78 - 19.44 |
| 52-Week Range | 15.50 - 21.78 |
| Beta | 0.64 |
| RSI | 68.54 |
| Earnings Date | Apr 24, 2026 |